Resveratrol Parkinson’s trial doses first patient
Jupiter Neurosciences also hired an adviser to explore a sale or licensing of its assets while the 30-person trial gets underway. Two pieces of news arrived in one press release from Jupiter Neurosciences earlier this month, and they pull in somewhat different directions. The Florida company dosed t
<p>Jupiter Neurosciences also hired an adviser to explore a sale or licensing of its assets while the 30-person trial gets underway. Two pieces of news arrived in one press release from Jupiter Neurosciences earlier this month, and they pull in somewhat different directions. The Florida company dosed t</p>